Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
Bristol-Myers takes a big step in its PD-1 lung cancer race with Merck
Fierce Biotech
Mon, 03/2/15 - 12:38 pm
Merck
Bristol-Myers Squibb
lung cancer
anti-PD-1 immunotherapy
Opdivo
Keytruda
Merck & Co., Inc. Gardasil 9 Gets Green Signal From CDC Committee
Bidness Etc.
Sat, 02/28/15 - 01:11 pm
Merck
vaccines
HPV
Gardasil 9
Which Cancer Immunotherapy Will Be the Most Successful?
Motley Fool
Sat, 02/28/15 - 12:50 pm
cancer immunotherapy
Opdivo
Bristol-Myers Squibb
Merck
Keytruda
anti-PD-1 immunotherapy
Merck takes equity, links up with diabetes drug developer NGM
bizjournals.com
Wed, 02/25/15 - 08:32 am
Merck
NGM Biopharmaceuticals
Global cancer drug market to grow to $111 billion by 2020: report
Medical Marketing and Media
Tue, 02/24/15 - 05:02 pm
cancer
cancer immunotherapy
Merck
Bristol-Myers Squibb
PD-1 inhibitors
Merck gives free license allowing cheap versions of its HIV drug for children in poor nations
Yahoo/AP
Tue, 02/24/15 - 09:18 am
Merck
HIV
developing countries
A Win for Merck? Paper Removes Investigation of Gardasil Side Effects
WSJ Pharmalot
Mon, 02/23/15 - 05:55 pm
Merck
vaccines
Gardasil
HPV
Merck Bets $450M on 'Old School' Biotech From NGM
Forbes
Mon, 02/23/15 - 08:42 am
Merck
NGM Biopharmaceuticals
MRNA
messenger RNA
Pharma's top 10 M&A deals of 2014
Fierce Pharma
Thu, 02/19/15 - 07:51 am
M&A
Actavis
Allergan
Forest Labs
GSK
Novartis
Bayer
Merck
Cubist Pharma
Roche
InterMune
Mylan Labs
Abbott Labs
Questcor
Mallinckrodt
Eli Lilly
Sun Pharma
Ranbaxy
Has Pfizer Inc. Finally Solved Its Immuno-oncology Problem?
Motley Fool
Wed, 02/18/15 - 10:56 am
Pfizer
immuno-oncology
AstraZeneca
Bristol-Myers Squibb
Merck
Roche
FirstWord Lists – The best selling drugs in 2014
First Word Pharma
Mon, 02/16/15 - 04:50 pm
Humira
Sovaldi
Remicade
Enbrel
Lantus
Rituxan
Advair
Avastin
Herceptin
Januvia
Merck
AbbVie
Gilead Sciences
JNJ
Amgen
Pfizer
Sanofi
Roche
GSK
Merck and Novo join an open-source R&D club with Amgen, Sanofi and Ono
Fierce Biotech
Tue, 02/10/15 - 10:40 am
R&D
Merck
Novo Nordisk
Amgen
Sanofi
Ono Pharmaceutical
Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving
WSJ Pharmalot
Tue, 02/10/15 - 08:41 am
patents
Big Pharma
Abilify
Amgen
AstraZeneca
Biogen Idec
Bristol-Myers Squibb
Crestor
Eli Lilly
Gilead Sciences
GSK
Harvoni
Hospira
Merck
Novo Nordisk
Pfizer
Sovaldi
Tecfidera
Merck Spars With British Columbia After its Diabetes Pill is Dropped
WSJ Pharmalot
Mon, 02/9/15 - 09:02 pm
Merck
Januvia
Canada
British Columbia
diabetes
Forget HDL, Merck Is Banking On LDL For Its Heart Drug, Anacetrapib
Forbes
Thu, 02/5/15 - 05:13 pm
Merck
LDL cholesterol
Anacetrapib
Moody's: Patent-cliff challenges will continue to dog big pharma
BioPharma Dive
Wed, 02/4/15 - 01:43 pm
patents
patent cliff
Big Pharma
Pfizer
Eli Lilly
Merck
Amgen
Novo Nordisk
AstraZeneca
Bristol-Myers Squibb
Drugmaker Merck posts spike in 4Q profit, beats forecasts
Yahoo/AP
Wed, 02/4/15 - 08:37 am
Merck
earnings
FDA yanks 'breakthrough' bragging rights to Merck's hep C combo
Fierce Biotech
Wed, 02/4/15 - 08:36 am
FDA
Merck
hepatitis C
grazoprevir
elbasvir
Merck finally rolls out sleep aid Belsomra after FDA roadblocks
Fierce Pharma
Wed, 02/4/15 - 08:34 am
Merck
Belsomra
insomnia
FDA
suvorexant
Merck & Co., Inc. (MRK) Q4 Earnings Preview: Expect Lower Sales And Earnings
Bidness Etc.
Mon, 02/2/15 - 08:17 am
Merck
earnings
Pages
« first
‹ previous
…
96
97
98
99
100
101
102
103
104
…
next ›
last »